Wall Street analysts expect DENTSPLY SIRONA Inc (NASDAQ:XRAY) to report earnings of $0.62 per share for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.57 to $0.66. DENTSPLY SIRONA reported earnings per share of $0.60 in the same quarter last year, which suggests a positive year over year growth rate of 3.3%. The company is expected to announce its next quarterly earnings results on Tuesday, August 6th.
According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.34 per share for the current fiscal year, with EPS estimates ranging from $2.31 to $2.37. For the next fiscal year, analysts anticipate that the business will post earnings of $2.64 per share, with EPS estimates ranging from $2.52 to $2.75. Zacks’ EPS averages are an average based on a survey of research analysts that cover DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The company had revenue of $946.20 million during the quarter, compared to the consensus estimate of $925.13 million. During the same period in the prior year, the firm earned $0.45 earnings per share. DENTSPLY SIRONA’s revenue was down 1.0% on a year-over-year basis.
XRAY stock traded down $0.40 during trading on Friday, reaching $54.49. The company had a trading volume of 76,048 shares, compared to its average volume of 1,711,197. DENTSPLY SIRONA has a 52 week low of $33.93 and a 52 week high of $55.88. The company has a market cap of $12.86 billion, a P/E ratio of 27.21, a PEG ratio of 2.05 and a beta of 1.11. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35.
In other news, SVP Daniel P. Key purchased 3,697 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were purchased at an average price of $54.68 per share, for a total transaction of $202,151.96. Following the completion of the acquisition, the senior vice president now directly owns 9,024 shares in the company, valued at approximately $493,432.32. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider William E. Newell sold 3,000 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $54.73, for a total transaction of $164,190.00. Following the sale, the insider now owns 28,212 shares in the company, valued at approximately $1,544,042.76. The disclosure for this sale can be found here. In the last 90 days, insiders sold 101,022 shares of company stock worth $5,535,985. Corporate insiders own 0.62% of the company’s stock.
Several large investors have recently bought and sold shares of the company. IFM Investors Pty Ltd boosted its holdings in shares of DENTSPLY SIRONA by 1.8% in the 4th quarter. IFM Investors Pty Ltd now owns 13,533 shares of the medical instruments supplier’s stock valued at $504,000 after acquiring an additional 245 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in shares of DENTSPLY SIRONA by 0.7% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 39,575 shares of the medical instruments supplier’s stock valued at $1,473,000 after purchasing an additional 268 shares during the period. Advisor Partners LLC grew its holdings in shares of DENTSPLY SIRONA by 3.1% in the first quarter. Advisor Partners LLC now owns 10,169 shares of the medical instruments supplier’s stock valued at $504,000 after purchasing an additional 304 shares during the period. Biltmore Family Office LLC grew its holdings in shares of DENTSPLY SIRONA by 5.8% in the first quarter. Biltmore Family Office LLC now owns 5,715 shares of the medical instruments supplier’s stock valued at $284,000 after purchasing an additional 315 shares during the period. Finally, Private Capital Group LLC grew its holdings in shares of DENTSPLY SIRONA by 105.3% in the fourth quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 359 shares during the period. Hedge funds and other institutional investors own 95.83% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: What is the Ex-Dividend Date in Investing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.